CD274 and neoplasm: This finding can potentially be explained by the significant increase of PD-L1 following single agent treatment with olaparib in the BRCA-deficient model, as the unique molecular properties BRCA-deficient tumor possess to promote STING pathway responses still remains unknown [88].